AVXL Soars Atop The OTC Wednesday

Have a wonderful weekend! We have been on the go, enjoying some down time while the market cools off a bit, but will be back to full speed shortly. There is a lot to look forward to over the coming months!

Sign Up For Our FREE E-mail Newsletter-> HERE <-To Receive Our Penny Stock Expert Picks Now!

Remember to visit our Twitter page for real-time updates, click here: Penny Stock Experts

Hi Everyone & Welcome New Subscribers,

Well, our wait on AVXL (Anavex Life Sciences Corp.) ended up being well worthwhile today, as shares made their way up to new a new 52 week high of .688, following the announcement this morning that results from their ongoing Phase 2a clinical trials have been overwhelmingly positive. Read the entire press release, HERE, to digest this information yourself.

The stock traded more than 13 million shares today and $8M, literally twice as much volume as the next closest US listed OTC stock under $1.00; quite an impressive feat to say the least.

All of the attention was on AVXL today, and it very well may continue higher; we will reassess in a few days and enjoy the sweet profits that were to be had for now!

Daily e-mail alerts will be soon forthcoming, so make sure you sign up to our e-mail list now to join our winning trading team!

Sign up-> NOW <-To Join Our E-mail List!

Happy Trading!

Sincerely,

The Penny Stock Experts Team At TodaysPickis.com 

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using Todayspickis.com or joining the email list. Todayspickis.com reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Todayspickis.com. Your continued use of the Todayspickis.com website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on Todayspickis.com/Disclaimer.html/. DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS. 

Neither Todayspickis.com nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered st ock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.

We are neither licensed nor qualified to provide investment advice. The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website.

Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. Todayspickis.com may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that Todayspickis.com and it’s affiliates can buy or sell more shares at any time. We can add or decrease this position at anytime following this e-mail or post. Todayspickis.com and/or it’s affiliates may receive compensation for e-mail alerts.

To view our full compensation disclosure please visit www.Todayspickis.com/Disclaimer.html. Todayspickis.com does not accept free-trading shares as a form of payment.

We hold up to 20,000 shares of AVXL (Anavex Life Sciences, Inc.) which we have purchased on the open market and can sell at any time following this post.